共查询到20条相似文献,搜索用时 15 毫秒
1.
Norihiro Kokudo MD Makoto Seki MD Hirotoshi Ohta MD Kaoru Azekura MD Masashi Ueno MD Tadao Sato MD Akihito Moroguchi MD Toshiki Matsubara MD Takashi Takahashi MD Toshifusa Nakajima MD Keisuke Aiba MD 《Annals of surgical oncology》1998,5(8):706-712
Background: Although the survival benefit of hepatic resection for colorectal metastasis has been established, some controversy remains regarding the significance of adjuvant chemotherapy after hepatic resection.
Methods: One hundred thirty-two consecutive patients who had liver resection for colorectal metastasis at our hospital between 1980 and 1997 were studied. After curative hepatic resection, 37 patients underwent systemic chemotherapy, administered orally or intraportally. Forty patients had no adjuvant chemotherapy. The chemotherapeutic agents used for oral administration were uracil and Tegafur or Tegafur alone. Mitomycin C (MMC) or 5-FU was used for IV chemotherapy. Combinations of 5-FU/leucovorin or MMC/5-FU (doxorubicin) were used for regional chemotherapy. Univariate and multivariate analyses were applied to test the significance of adjuvant chemotherapy for patient survival or disease-free survival.
Results: Overall 5-year survival was 42.2% (95% CL: 31.2%, 53.2%). Among the possible prognostic factors studied, univariate analysis showed a significant difference in survival based on the number of tumors and lymph node metastases in the hepatic hilum. There was a significant difference in disease-free survival based on adjuvant chemotherapy and lymph node metastasis. The multivariate analysis for patient survival selected four prognostic factors (P<.05), including adjuvant chemotherapy, lymph node metastasis, disease-free interval, and tumor size. The multivariate analysis for disease-free survival selected adjuvant chemotherapy, lymph node metastasis, and disease-free interval as significant factors. The most common recurrence site was remnant liver, regardless of adjuvant chemotherapy.
Conclusions: Adjuvant chemotherapy significantly improved survival and disease-free survival after hepatic resection for colorectal metastases. It did not decrease recurrence rate in the remnant liver.Presented at the 51st Annual Cancer Symposium of The Society of Surgical Oncology, San Diego, California, March 26–28, 1998. 相似文献
2.
目的探讨同步切除治疗胃癌并局限型肝转移的临床效果。方法回顾性分析胃癌并局限型肝转移行同步切除的9例患者的临床资料。结果行根治性远端胃大部分切除术7例,根治性近端胃大部分切除术1例,根治性全胃切除1例;局部肝切除8例,左半肝切除1例。无手术死亡病例。术后生存期分别为9、12、12、13、21、24、30、37和62个月,平均生存24.3个月。术后6例再发残肝转移。死亡原因中,3例死于残肝转移,3例死于腹膜转移。结论对胃癌并局限型肝转移患者施行原发灶根治性切除和肝转移灶同步切除可有效地延长生命。 相似文献
3.
BackgroundIn the international literature we have never found a long survival in patients treated for a colon cancer with synchronous hepatic metastases and for a metachronous Krukenberg tumor.Presentation of caseA 46-year old woman for an advanced colon cancer with a synchronous hepatic metastases was subjected to a left hemicolectomy and a resection of liver segment V (R0 resection; T4N2bM1; stage IVa according AJCC 2010). After one year a CT of the abdomen revealed an expansive formation of the left ovary. The patient was subjected to a bilateral ovariectomy, hysterectomy and hiperthermic intraperitoneal chemotherapy (HIPEC). The patient, after several cycles of adjuvant chemotherapy, is disease-free 13 years after surgery.DiscussionTo our knowledge, in the literature there do not appear to be cases of such disease-free survival. The survival of patient despite the prognostic indexes is discussed. The authors discus the importance of an adequate surgical treatment especially for liver metastases simultaneously treated to colon cancer. The authors also focus on chemotherapy (FOLFOX and then FOLFIRI) performed in a pre-biological era. Furthermore, the degree to which the HIPEC may have had an impact is still unknown, although it seems to be the gold standard for the treatment of the microscopic peritoneal neoplastic remnant.ConclusionThe authors emphasize that the long term survival in colon cancer with hepatic and ovarian metastases is possible as long as it has an adequate surgical approach, a tailored chemotherapy and an intensive follow-up. Most likely new prognostic markers will have to be identified. 相似文献
4.
Sunao Uemura Hiromichi Maeda Masaya Munekage Ryuji Yoshioka Takehiro Okabayashi Kazuhiro Hanazaki 《Journal of gastrointestinal surgery》2009,13(9):1724-1727
Background Situs inversus totalis is a rare condition characterized by a mirror-image transposition of the abdominal and thoracic viscera.
In order to develop safe techniques for hepatic resection, it is important to report surgical outcomes in cases complicated
by situs inversus totalis and other anomalies.
Case The patient was a 64-year-old man with situs inversus totalis who had previously undergone sigmoidectomy with regional lymphadenectomy
for sigmoid colon cancer at age 62. Despite postoperative adjuvant chemotherapy, tumor markers increased and multiple liver
metastases were detected on abdominal ultrasonography. Enhanced computed tomography revealed not only liver metastases but
also hepatobiliary anomalies associated with situs inversus totalis as follows: (1) portal vein located anterior to the common
bile duct or hepatic artery, (2) proper hepatic artery arising from the superior mesenteric artery, (3) “left” (right in normal
population)-sided umbilical portion of the portal vein and total ramification of intrahepatic portal branches from that point,
(4) hepatic vein directly communicating to the “left” atrium. For the treatment of hepatic metastases from sigmoid colon cancer
in a patient with situs inversus totalis, “left” hepatic lobectomy, partial hepatectomy, and radiofrequency ablation therapy
were performed. The postoperative course was uneventful. Adjuvant chemotherapy has been continued for 2 years after the second
operation and the patient is doing well without recurrence.
Conclusion Since situs inversus totalis is occasionally accompanied by multiple hepatobiliary anomalies, careful evaluation of the related
anatomy using modern imaging modalities is crucial for safe hepatic resection. 相似文献
5.
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment 总被引:17,自引:0,他引:17
Overall, hepatic resection appears to be an important means of curing patients with metastatic colorectal cancer isolated to the liver. The only absolute contraindication to surgery was the impossibility of a radical removal of tumor: if residual disease will remain after the hepatic resection, this operation is not indicated. A possible second contraindication to surgery is the presence of tumor in the hepatic or celiac lymph nodes. Such metastases from liver metastases signal a biologic grade of tumor that is almost sure to spread to other sites. However, one patient of the 25 in this group did survive long term when positive lymph node groups were dissected. Further clinical experience with this form of the disease along with trials of regional adjuvant therapies such as intraperitoneal chemotherapy may be needed. The presence of extrahepatic metastases at the time of liver resection should be considered a relative contraindication to this surgery, but if the patient can be made clinically disease free, long-term disease-free survival may result. It seems imperative that all patients with hepatic metastases be evaluated by an experienced hepatic surgeon for a curative resection. If the patient has between one and four metastases, a 25 per cent long-term disease-free survival rate can be expected. Patients who have a radical resection of more than four metastases should be considered to be in an experimental group in whom more data are needed. In our current state of knowledge, making such patients clinically disease free is their only chance for long-term survival. Other factors besides the number of metastases that will affect the prognosis of the patient include the disease-free interval between colorectal resection and liver resection, the pathologic margin of resection on the liver specimen, and the presence or absence of mesenteric lymph node metastases from the primary cancer. These factors should be considered when determining the prognosis in a given patient and should be used as stratification variables in prospective trials. However, from our analysis of available data, these factors should not be considered contraindications to hepatic resection. 相似文献
6.
Yoshito Kiyasu 《International surgery》2013,98(3):241-246
This report describes a 58-year-old woman with gastric adenocarcinoma and liver metastases, who survives for more than 18 years after diagnosis. At diagnosis and first surgery, a moderately differentiated gastric adenocarcinoma with subserosal invasion was detected, along with 2 regional lymph node metastases and 2 liver metastases. She underwent gastrectomy and regional lymph node dissection but did not undergo liver operation then. After gastrectomy, she received adjuvant chemotherapy for 1 month but discontinued it due to severe diarrhea. Another metastasis in another area of the liver was detected, for which she underwent excision of the right lobe of the liver (subsegments 5, 6, and 7) about 30 months later. No signs of recurrence have been detected for 18 years (as of March 2012). This patient represents a rare case of long-term survival of gastric adenocarcinoma without recurrence after surgical treatment, despite multiple, synchronous, liver and regional lymph node metastases. 相似文献
7.
Clinicopathological Features and Prognosis in Resectable Synchronous and Metachronous Colorectal Liver Metastasis 总被引:12,自引:0,他引:12
Introduction Hepatic resection may offer long-term survival for patients with colorectal metastases. However, controversies exist regarding
the prognostic factors. Herein, the impact of synchronicity of liver metastasis on patient clinicopathological features and
prognosis was evaluated.
Methods One hundred and fifty-five patients who underwent hepatectomy for colon cancer metastasis, from 1995 to 2004, were enrolled
in this study. Patients were divided into two groups: synchronous and metachronous colorectal liver metastasis. Patient demographics,
the nature of the primary and metastatic tumors, surgery-related complications, and long-term outcome were analyzed.
Results Patients included in the synchronous group tended to be younger than those in the metachronous group. Compared to the metachronous
group, patients in the synchronous group showed more metastases (P = 0.008) and bilobarly distributed metastases (P = 0.016). Bile leakage was the most common surgical complication. The estimated 5-year disease-free and overall survival rates
were 16.8 and 41.1%, respectively. Univariate analysis indicated that synchronous metastases, advanced stage of the primary
tumor, bilobar distribution of the metastases, more than three metastases, and colonic versus rectal location of the primary
tumor were prognostic factors of shorter disease-free survival, but not overall survival. Multivariate analysis revealed that
synchronous metastases and the advanced stage of the primary tumor were indicators for a worse disease-free survival.
Conclusion The synchronous presence of primary colon cancer and liver metastasis may indicate a more disseminated disease status and
is associated with a shorter disease-free survival than metachronous metastasis. These patients may need more careful monitoring
and aggressive chemotherapy following curative resection. 相似文献
8.
Ҷӱ������ ɼ 《中国实用外科杂志》2009,29(9):728-732
??Treatment strategies for management of colorectal cancer liver metastases YE Ying-jiang, WANG Shan. Department of Gastroenterology Surgery, Peking University People’s Hospital, Beijing 100044, China Corresponding author:YE Ying-jiang, E-mail:yjye101@yahoo.com.cn Abstract Liver metastases is the most common distant metastasis of colorectal cancer. Surgical resection is believed the only effective treatment for metastatic hepatic cancer currently. With increased experience and multiple disciplines development, the surgical indication for metastatic liver cancer has been expanded gradually, and the standard of hepatic surgery has also been improved constantly. Importantly, multidisciplinary team (MDT) model remains the fundamental for optimal treatment for liver metastasis from colorectal cancer. The participation of MDT brings more opportunities for metastatic liver cancer, and improves the surgery outcomes indirectly. Diagnostic radiology is an important way for R0 resection of metastatic liver cancer; the intraoperative ultrasound increases metastatic liver cancer detection rate and surgery safety. Preoperative chemotherapy brings operation opportunity for those patients with initially unresectable lesions, and postoperative adjuvant therapy contributes to reduce the post-operation recurrence and metastasis. Radiofrequency ablation combined with hepatic resection provides unresectable metastatic liver cancer the best opportunity for long term survival. 相似文献
9.
胃肠肿瘤根治联合肝移植术治疗晚期胃肠肿瘤并肝脏广泛转移 总被引:2,自引:0,他引:2
目的 总结胃肠肿瘤根治联合肝移植治疗晚期胃肠肿瘤并发肝脏多发转移的近期疗效。方法 1例胃癌和2例直肠癌并发肝脏多发转移患者,分别接受胃癌和直肠癌根治、联合原位同种异体肝移植手术,其中1例因肺结核同时行左上肺部分切除术。结果 3例患者无围手术期死亡。随访5-7个月,胃癌患者术后5个月死于肿瘤复发;1例直肠癌并肺结核患者术后7个月死于肝功能衰竭,无肿瘤复发;另1例直肠癌患者已完成3个月化疗,术后半年无复发,肝功能和血常规正常,精神食欲好,已恢复工作。结论 胃肠肿瘤根治联合肝移植为部分晚期肿瘤患者提供了生存的希望,远期效果有待进一步观察。 相似文献
10.
Johannes Zacherl M.D. Maximilian Zacherl M.D Christian Scheuba M.D. Rudolf Steininger M.D. Etienne Wenzl M.D. F.R.C.S. Ferdinand Mühlbacher M.D. Raimund Jakesz M.D. Friedrich Längle M.D. 《Journal of gastrointestinal surgery》2002,6(5):682-689
Few patients with metastatic gastric cancer have disease that is amenable to curative surgery. Thus far, little is known about
liver surgery for metastases arising from gastric adenocarcinoma and prognostic factors. Of 73 patients operated on between
1980 and 1999 for noncolorectal, non-neuroendocrine hepatic metastases, 15 underwent liver resection for gastric adenocarcinoma
metastasis. Ten patients underwent synchronous hepatic resection and five underwent metachronous hepatic surgery after a median
diseasefree interval of 10 months (range 6.1 to 47.3 months). None of the patients died within the first 30 days after surgery,
and the in-hospital mortality rate was 6.7%. Among patients in the synchronous group, 26.7% experienced major complications
mainly associated with gastric surgery. Overall median survival was 8.8 months (range 4 to 51 months); two patients survived
more than 3 years. Univariate analysis reealed that the appearance of liver metastasis synchronous vs. metachronous), the
distribution of liver metastases (unilobar vs. bilobar), and the primary tumor site (proximal vs. distal) were marginally
signifiant predictive factors regarding overall survival. Because of its high morbidity, synchronous liver resecion for metastases
originating from gastric adenocarcinoma is rarely followed by survival longer than 2 years. Primary tumor localization within
the proximal third of the stomach and bilobar liver involvement appear to be predictive of poor outcome. On the other hand,
curative resection of metachronous liver metastases may allow long-term survival in selected patients. 相似文献
11.
Interval Period Tumor Progression: Does Delayed Hepatectomy Detect Occult Metastases in Synchronous Colorectal Liver Metastases? 总被引:2,自引:0,他引:2
Hiroyuki Yoshidome Fumio Kimura Hiroaki Shimizu Masayuki Ohtsuka Atsushi Kato Hideyuki Yoshitomi Katsunori Furukawa Noboru Mitsuhashi Dan Takeuchi Ayako Iida Masaru Miyazaki 《Journal of gastrointestinal surgery》2008,12(8):1391-1398
Background Rapid remnant liver recurrence in patients with synchronous colorectal liver metastases (CRLM) is occasionally experienced
after simultaneous colorectal and liver resection. We evaluated the tumor progression during interval periods to determine
whether delayed hepatic resection detects occult metastases.
Methods One hundred thirty-seven patients underwent hepatectomy for synchronous CRLM. Up to 2003, 116 patients underwent simultaneous
colorectal and hepatic resection. From 2004 onward, we identified 21 patients undergoing delayed hepatectomy for synchronous
CRLM. The tumor progression during interval was determined by a dynamic computed tomography scan.
Results Median/mean interval between the two evaluations prior to the first and second surgery was 2/2.4 months. The median/mean number
of metastases detected at each evaluation was 2/3.3 and 3/4.6, respectively. Nine of the 21 (43%) patients had new detectable
metastatic lesions after reevaluation. For 11 of the 21 patients, it was necessary to reconsider planned surgical procedure
which was determined prior to colorectal surgery. Hepatic disease-free survival was significantly different between patients
undergoing delayed and simultaneous hepatectomy. Multivariate analysis showed that the delayed hepatectomy was a significant
independent prognostic factor in hepatic disease-free survival.
Conclusion Tumor progression was recognized and occult metastases were detected after the interval reevaluation. Delayed hepatectomy
may be a useful approach to reduce rapid remnant liver recurrence in synchronous CRLM. 相似文献
12.
S Ambiru M Miyazaki H Ito K Nakagawa H Shimizu N Nakajima 《The British journal of surgery》1999,86(8):1025-1031
BACKGROUND: This study explored the possibility of achieving a better survival rate and reduced recurrence in the remaining liver in patients with colorectal hepatic metastases undergoing hepatic resection. Adjuvant postoperative regional chemotherapy was administered via the hepatic artery or the portal vein. METHODS: A retrospective study was performed on 174 patients after hepatic resection for colorectal metastases. These comprised 78 patients who had hepatic artery infusion (HAI) chemotherapy (HAI group), 30 who had portal vein infusion (PVI) chemotherapy (PVI group) and 66 who had no regional chemotherapy (resection alone group). The three groups were compared with one another in terms of complications, survival rate and patterns of recurrence. RESULTS: Severe complications did not occur at any point during adjuvant HAI or PVI chemotherapy. The 5-year disease-free survival rate of patients in the HAI, PVI and resection alone groups were 35, 13 and 9 per cent respectively, including six hospital deaths. Patients in the HAI group showed significantly improved recurrence rates in the remaining liver compared with the resection alone group (P = 0.03), and more prolonged disease-free and overall survival than those in the PVI (P = 0.01 and P = 0.02 respectively) and resection alone (P = 0.0001 and P = 0.0006 respectively) groups. CONCLUSION: This study suggests that adjuvant HAI chemotherapy after hepatic resection may have therapeutic potential for improved management of patients with colorectal metastases. 相似文献
13.
Sotaro Sadahiro Toshiyuki Suzuki Akira Tanaka Kazutake Okada Hiroko Kamata Jun Koisumi 《Surgery today》2013,43(10):1088-1094
The most common site of metastases in patients with colorectal cancer is the liver. Hepatic resection is considered to be the treatment of choice for liver metastasis from colorectal cancer; however, hepatic resection can be performed in only 20 or 25 % of all patients. Recurrence develops in the remnant liver or other organs after hepatic resection in over half of all patients with liver-only metastasis. Hepatic arterial infusion (HAI) chemotherapy can provide relatively high concentrations of drugs to microscopic or macroscopic metastases in the liver, with less toxicity than systemic administration. Meta-analyses have shown HAI chemotherapy to have a significantly higher response rate than systemic chemotherapy and its effect on extrahepatic metastases is negligible. HAI chemotherapy provides much better local control of liver metastases from colorectal cancer than systemic chemotherapy. However, well-controlled studies are needed to elucidate the optimal treatment strategies for neoadjuvant and postoperative adjuvant chemotherapy that optimally combine HAI chemotherapy, molecular targeted agents, and systemic chemotherapy such as FOLFOX or FOLFIRI. 相似文献
14.
目的:探讨腹腔镜结直肠癌切除术加辅助化疗加二期内镜下治疗结直肠癌合并根治术切除范围外结直肠腺瘤的临床应用价值。方法:2005年1月-2010年6月对54例进展期结直肠癌合并根治术切除范围外结直肠腺瘤(〉1.0cm)的患者(研究组)行腹腔镜结直肠癌切除术加辅助化疗(FOLFOX4方案)加二期内镜下腺瘤切除的综合治疗,对同期396例单发进展期结直肠癌患者(对照组)行腹腔镜结直肠癌切除术加辅助化疗(FOLFOX4方案)。通过并发症发生率、长期随访等评价治疗效果。结果:2组患者在年龄、性别、手术方式、手术时间、术中出血量、并发症发生率、平均住院时间、肿瘤大小、淋巴结转移、TNM分期及1、3和5年存活率差异无统计学意义(P〉O.05)。研究组辅助化疗后对合并腺瘤进行内镜下切除治疗,4例出血经保守治疗后成功止血,未发生穿孔、狭窄等严重并发症;3例患者术后病理组织学检查为腺瘤癌变,其中2例癌变局限于腺瘤中,1例癌细胞侵犯达黏膜下层,该例患者再次行腹腔镜下切除,术后随访无复发。结论:腹腔镜联合辅助化疗及内镜为合并结直肠癌根治术切除范围外腺瘤的患者提供了一种安全有效的微创治疗方法,值得临床推厂和应用。 相似文献
15.
Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients 总被引:19,自引:0,他引:19
Sakamoto Y Ohyama S Yamamoto J Yamada K Seki M Ohta K Kokudo N Yamaguchi T Muto T Makuuchi M 《Surgery》2003,133(5):507-511
BACKGROUND: The justification for surgical resection of liver metastases from gastric cancer remains controversial. METHODS: Twenty-two patients who underwent 26 hepatectomies for liver metastases of gastric cancer between 1985 and 2001 were analyzed. Fifteen clinicopathologic factors were evaluated with univariate and multivariate analyses for survival after hepatic resection. RESULTS: The overall 1-year, 3-year, and 5-year survival rates after hepatectomy for gastric metastases were 73%, 38%, and 38%, respectively. Five patients survived for more than 3 years without recurrence, 3 of whom had synchronous metastases resected at the time of gastrectomy. The best results after surgical resection for liver metastases of gastric cancer were obtained with solitary metastases less than 5 cm in size. The number of liver metastases (solitary or multiple) was the only significant prognostic factor according to both univariate and multivariate analyses. CONCLUSION: Surgical resection for liver metastases of gastric cancer may be beneficial for patients with a solitary metastasis, whether it is synchronous or metachronous. 相似文献
16.
Treatment strategy for synchronous metastases of colorectal cancer: is hepatic resection after an observation interval appropriate? 总被引:1,自引:1,他引:0
Yasuhiro Shimizu Kenzo Yasui Tsuyoshi Sano Takashi Hirai Yukihide Kanemitsu Koji Komori Tomoyuki Kato 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2007,392(5):535-538
Background In cases of synchronous colorectal hepatic metastases, the primary colorectal cancer strongly influences on the metastases.
Our treatment policy has been to conduct hepatic resection for the metastases at an interval of 3 months after colorectal
resection. We examined the appropriateness of interval hepatic resection for synchronous hepatic metastasis.
Materials and methods The subjects were 164 patients who underwent resection of hepatic metastasis of colorectal cancer (synchronous, 70 patients;
metachronous, 94 patients). Background factors for hepatic metastasis and postoperative results were compared for synchronous
and metachronous cases.
Results The cumulative survival rate for 164 patients at 3, 5, and 10 years postoperatively was 71.9%, 51.8%, and 36.6%, and the post-resection
recurrence rate in remnant livers was 26.8%. Interval resection for synchronous hepatic metastases was conducted in 49 cases
after a mean interval of 131 days. No difference was seen in postoperative outcome between synchronous and metachronous cases.
Conclusion The outcome was similarly favorable in cases of synchronous hepatic metastasis and in cases of metachronous metastasis. Delaying
resection allows accurate understanding of the number and location of hepatic metastases, and is beneficial in determining
candidates for surgery and in selecting surgical procedure. 相似文献
17.
Grundmann RT 《Zentralblatt für Chirurgie》2007,132(4):287-292
The economic analysis of surgery in colorectal liver metastases reveals the different effectiveness of various follow-up programmes after curative surgery for colorectal cancer. Interval hepatic resection for synchronous liver metastases is recommended in the majority of cases with rectal cancer. This procedure provides benefits for the patient and the hospital under the economic point of view. The interval between primary tumor resection and surgery of liver metastases does not deteriorate the prognosis, on the contrary, unnecessary resections will be avoided if additional metastases will grow in the time between, excluding curative treatment (selection mechanism). The identical statement cannot be applied to patients with colon cancer, since the operative risk is only slightly increased in case of easily accessible liver metastases which may be removed simultaneously. However, also in these patients interval hepatic resection after neoadjuvant chemotherapy should be considered as a therapeutic option! In patients with multiple liver metastases liver surgery as well as radiofrequency ablation or a combination of both may be economically justified. Radiofrequency ablation is the preferred palliative procedure under aspects of cost-effectiveness, however, wether this procedure is superior to chemotherapy alone has not be evaluated so far in prospectively randomized trials. 相似文献
18.
Glenn Steele Robert T. Osteen Richard E. Wilson David C. Brooks Robert J. Mayer Norman Zamcheck Thanjavur S. Ravikumar 《American journal of surgery》1984,147(4):554-559
During a period of 7 years, we have aggressively treated liver tumors whether primary or metastatic. Our experience after 43 curative major liver resections has shown an excellent overall survival: 34 of 43 patients still alive a median of 12 months after liver resection (patient ages ranged from 21 to 85 years, median 57 years). Nineteen patients underwent right hepatic lobectomy, 9 trisegmentectomy, 5 left hepatic lobectomy, 5 extended left hepatic lobectomy, 4 right lobectomy plus left lobe wedge resection, and 1 patient underwent a major hilar wedge resection. Two patients died from sepsis and hepatic failure on or before the 60th postoperative day. One patient with no evidence of recurrent colorectal cancer was lost to follow-up after 2.5 years. One patient died without cancer 12 months after left hepatic lobectomy for colon cancer metastases. Cumulative survival for the entire series and for patients after resection of colorectal cancer metastases was the same: 1 year survival 90 percent; 2 year survival 75 percent, and 3 year survival 65 percent. Seventeen of 30 patients remain disease-free after resection of liver metastases. Of the 13 who had recurrence, 8 are still alive. Ten recurrences were outside of the residual liver (predominantly multiple pulmonary metastases). One recurrence was in the right hemidiaphragm, and only three were in the residual or regenerated liver. Serial carcinoembryonic antigen analysis was the best indicator of recurrence in these 13 patients, 12 of whom were asymptomatic. These data confirm that major liver resection can be performed with minimum postoperative mortality (4.7 percent in this series). More importantly, the majority of patients were cured of their liver metastases. The next goal should be the initiation of adjuvant systemic therapy trials after liver resection in such patients. 相似文献
19.
Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases 总被引:15,自引:0,他引:15
Laurent C Sa Cunha A Couderc P Rullier E Saric J 《The British journal of surgery》2003,90(9):1131-1136
BACKGROUND: Survival after resection of colorectal liver metastases may be influenced by the patient, the primary tumour and the liver metastases. Postoperative morbidity is associated with poor survival in several cancers. The aim of this retrospective study was to evaluate prognostic factors of survival after resection of colorectal liver metastases, including postoperative morbidity. METHODS: From 1985 to 2000, 311 consecutive patients with liver metastases from colorectal cancer underwent resection with curative intent. Univariate and multivariate analyses were performed to assess the influence of age, sex, site and stage of the colorectal tumour, disease-free interval, number, size and distribution of metastases, type of hepatectomy, pedicular clamping, resection margin, blood transfusion, postoperative morbidity and adjuvant chemotherapy on overall and disease-free survival. RESULTS: The postoperative mortality and morbidity rates were 3 and 30 per cent respectively. The 3- and 5-year overall survival rates were 53 and 36 per cent respectively. Both overall and disease-free survival rates were independently associated with nodal status of the colorectal tumour, number of metastases and postoperative morbidity. Patients with postoperative morbidity had an overall and disease-free 5-year survival rate half that of patients with no morbidity: 21 versus 42 per cent for overall survival (P < 0.001) and 12 versus 28 per cent for disease-free survival (P = 0.001) respectively. CONCLUSION: Long-term survival can be altered by postoperative morbidity after resection of colorectal liver metastases by increasing the risk of tumour recurrence. This justifies optimizing the surgical treatment of colorectal liver metastases to decrease postoperative morbidity and the use of efficient adjuvant treatments in patients with postoperative morbidity. 相似文献
20.
IntroductionGastric cancer with paraaortic lymph node (PAN) metastasis have unfavorable prognosis. There are no evidence-based preoperative chemotherapy regimens available.Case presentationA 62-year-old female was diagnosed with advanced gastric cancer and PAN metastasis. We attempted S-1/CDDP chemotherapy in six coursed and total gastrectomy as well as systematic dissection of regional lymph nodes and PAN. Histologically, no cancerous cells were detected in specimens. The patient has been disease-free for 5 years since the surgery.DiscussionLong-term survival case of gastric cancer with PAN metastasis attaining pathologically complete response is extremely rare. It is possible that preoperative S1/CDDP with surgery might be a standard treatment strategy for gastric cancer with PANs.ConclusionWe report herein a rare case of gastric cancer with PAN metastases who achieved a 5-year survival after S-1/CDDP chemotherapy and surgery. 相似文献